STOCKHOLDERS' EQUITY |
6 Months Ended |
|---|---|
Jun. 30, 2022 | |
| STOCKHOLDERS' EQUITY | |
| STOCKHOLDERS' EQUITY |
NOTE 10 – STOCKHOLDERS’ EQUITY During the year ended December 31, 2021, the remaining 13,428,500 pre-funded warrants and 442,600 of common warrants were exercised. Gross proceeds from these transactions were $367,509. On April 5, April 6, and April 7, 2022, a total of 6,453,907 of common warrants were exercised at a price of $0.80 per share. At June 30, 2022, there remained 22,907,793 unexercised common warrants, with an exercise price of $0.80 per share. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|